Subsequent treatment of epidermal growth factor receptor-tyrosine kinase inhibitor failure in patients with advanced lung adenocarcinoma

BACKGROUND: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) effectively treat advanced non-small cell lung cancer with EGFR-mutation. However, most patients develop acquired resistance without effective therapy subsequent to EGFR-TKI failure. We evaluated the efficacy of subs...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Qiao, Xiaojuan, Zhang, Ye, Wang, Jinghui, Nong, Jingying, Li, Xi, Yang, Xinjie, Lv, Jialin, Zhang, Hui, Qin, Na, Zhang, Quan, Yue, Wentao, Zhang, Shucai
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2015
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4632918/
https://ncbi.nlm.nih.gov/pubmed/26557904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12236
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados